TrialBMC cancer2024

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.

Elena Elez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.